CLX-0101

N/A

Report date: 2023/02/11 20:37:47

Base Information

Drug NameCLX-0101
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptideSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionInsulin sensitizers
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCalyxt Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCalyxt Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A